571 - 580 of 9033 Results
Title
Year
-
RESTRICTEDTitle: Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluidJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 1179End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41596-022-00787-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561622Citation Count: 35
- Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options2018RESTRICTEDTitle: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current optionsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 352Issue #:Start Page: 142End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014Citation Count: 20
-
RESTRICTEDTitle: Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseasesJournal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1237End Page: 1245Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2016.1182990Best OA location URL: https://europepmc.org/articles/pmc5315368?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of actionJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 21Issue #: 5Start Page: 802End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013Citation Count: 246
- Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid2019RESTRICTEDTitle: Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluidJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 59Issue #:Start Page: 21End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.016Citation Count: 16
- Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?2023RESTRICTEDTitle: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdfCitation Count: 5
-
RESTRICTEDTitle: Small Molecules to Improve ER Proteostasis in DiseaseJournal Name: Trends in Pharmacological SciencesPublisher: Elsevier BVVol: 40Issue #: 9Start Page: 684End Page: 695Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.tips.2019.07.003Best OA location URL: http://manuscript.elsevier.com/S0165614719301403/pdf/S0165614719301403.pdfCitation Count: 63
-
RESTRICTEDTitle: Clinical neurophysiology of Parkinson’s disease and parkinsonismJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 7Issue #:Start Page: 201End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002Citation Count: 33
- Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s2014RESTRICTEDTitle: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’sJournal Name:Publisher:Vol:Issue #:Start Page: 22End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1Citation Count: 1
-
RESTRICTEDTitle: Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”Journal Name: ACS Applied Materials & InterfacesPublisher: American Chemical Society (ACS)Vol: 15Issue #: 10Start Page: 13824End Page: 13824Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acsami.3c02300Best OA location URL: https://doi.org/10.1021/acsami.3c02300Citation Count: 0